1. Home
  2. VERO vs SCNI Comparison

VERO vs SCNI Comparison

Compare VERO & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Venus Concept Inc.

VERO

Venus Concept Inc.

HOLD

Current Price

$1.82

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$1.23

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERO
SCNI
Founded
N/A
2003
Country
Canada
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VERO
SCNI
Price
$1.82
$1.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
36.1K
41.7K
Earning Date
11-13-2025
11-24-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$58,876,000.00
$1,147,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.00
N/A
P/E Ratio
N/A
$4.55
Revenue Growth
N/A
303.87
52 Week Low
$1.65
$0.86
52 Week High
$14.50
$6.18

Technical Indicators

Market Signals
Indicator
VERO
SCNI
Relative Strength Index (RSI) 46.16 55.65
Support Level $1.84 $1.14
Resistance Level $1.99 $1.30
Average True Range (ATR) 0.12 0.08
MACD 0.01 0.04
Stochastic Oscillator 44.78 76.16

Price Performance

Historical Comparison
VERO
SCNI

About VERO Venus Concept Inc.

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: